110 likes | 258 Views
The cost of removing financial barriers to treatment uptake and adherence as effective public health strategies for improving health and reducing HIV transmission in Australia. Lance Feeney - Positive Life NSW (No conflicts of interest to declare) . Background.
E N D
The cost of removing financial barriers to treatment uptake and adherence as effective public health strategies for improving health and reducing HIV transmission in Australia Lance Feeney - Positive Life NSW (No conflicts of interest to declare)
Background • The Australian Seventh National HIV Strategy 2014-2017 targets • NSW HIV Strategy 2012-2015: A New Era • Australian PBS subsidised medicines (patient co-payment) • Financial stress and cost of ART co-payments are barriers to treatment uptake and adherence • PLHIV experience higher rates of co-morbidity • Decisions about ART initiation and adherence are negatively impacted by cost of ART and non-ART medications
Background cont. • A case for Australian Governments reducing the cost burden of ART, particularly for those experiencing financial stress • Annual cost of each new HIV infection is $13,800 - $16,300 for those on 1st or 2nd line ART • Annual cost for those on 3rd line ART is $19,000 • The life time cost of each new HIV infection is estimated to be approximately $483,000 - $570,000 (1st/2nd) and $665,000 (3rd line ART)
Methods PBS Co-payment rates & employment percentages Number of ART items dispensed per person
Full and Concessional patient cost for ART/non-ART medications over 12 months
Yearly cost to Government of waiving ART co-payments for 10,500 people with diagnosed HIV in NSW - 2014
Yearly cost to Government of waiving co-payments for 15%-20% of people with undiagnosed HIV in NSW - 2014 So for less than $6 million per year 90% of all people with diagnosed and undiagnosed HIV could be treated free It could cost $5.2 million per year at 80% treatment uptake
Progress in other Australian States and Territories • New South Wales - • Victoria - Detailed analysis commissioned by Victorian AIDS Council and Living Positive Victoria and conducted by Burnet Institute • Queensland – Proposal viewed with merit, but yet to be approved for implementation • South Australia – Positive Life South Australia developing state-based submission • Western Australia – ART co-payments waived • Northern Territory – ART co-payments waived • Tasmania and the Australian Capital Territory ?
Conclusion • Mixed result to reduce cART cost burden • Improving rates of ART in NSW • But, still PLHIV minority with poorer health, drug and alcohol and poverty issues • Achieving 2015 treatment and prevention targets will require addressing barriers to cART • A case to build this into the public health response
Acknowledgments • Jo Watson – NAPWHA (co-author) • Bill Whittaker – NAPWHA • Albion Centre Pharmacy • St. Vincent’s Hospital Pharmacy • PozAction members: • Queensland Positive People • Living Positive Victoria • Positive Life South Australia